Literature DB >> 27392931

Nuclear localization of Toll-like receptor 5 in Barrett's esophagus and esophageal adenocarcinoma is associated with metastatic behavior.

Olli Helminen1,2,3,4,5, Heikki Huhta6,7,8,9,10, Joni Leppänen6,7,8,9,10, Joonas H Kauppila6,7,8,9,10, Heikki Takala10, Petri P Lehenkari7,8,9,10, Juha Saarnio7,9,10, Tuomo J Karttunen6,9,10.   

Abstract

Toll-like receptor 5 (TLR5) recognizes bacterial flagellin. Increased cytoplasmic and nuclear expression of some TLRs has been previously reported in dysplasia in Barrett's esophagus and various malignant lesions in association with survival and metastasis. We assessed nuclear expression of TLR5 in Barrett's esophagus and esophageal adenocarcinoma (n = 94) by immunohistochemistry and immunofluorescent staining. Nuclear expression was observed in the majority of studied lesions with high variation in the proportion of positive nuclei. Expression in lymph node metastases was significantly higher than in esophageal lesions (p < 0.05), except for intestinal metaplasia and low-grade dysplasia. Furthermore, nuclear expression of TLR5 was associated with the presence of lymph node metastases (p = 0.033). In conclusion, we report nuclear TLR5 expression in Barrett's esophagus and adenocarcinoma. Abundance of positive nuclei in association with lymph node metastases suggests that TLR5 is involved in the pathogenesis and dissemination of esophageal adenocarcinoma through as-yet-uncharacterized mechanisms.

Entities:  

Keywords:  Barrett’s esophagus; Cell nucleus; Esophageal adenocarcinoma; Toll-like receptor 5

Mesh:

Substances:

Year:  2016        PMID: 27392931     DOI: 10.1007/s00428-016-1989-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  15 in total

1.  NucPred--predicting nuclear localization of proteins.

Authors:  Markus Brameier; Andrea Krings; Robert M MacCallum
Journal:  Bioinformatics       Date:  2007-03-01       Impact factor: 6.937

2.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5.

Authors:  F Hayashi; K D Smith; A Ozinsky; T R Hawn; E C Yi; D R Goodlett; J K Eng; S Akira; D M Underhill; A Aderem
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

3.  Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.

Authors:  Cathy Bennett; Nimish Vakil; Jacques Bergman; Rebecca Harrison; Robert Odze; Michael Vieth; Scott Sanders; Laura Gay; Oliver Pech; Gaius Longcroft-Wheaton; Yvonne Romero; John Inadomi; Jan Tack; Douglas A Corley; Hendrik Manner; Susi Green; David Al Dulaimi; Haythem Ali; Bill Allum; Mark Anderson; Howard Curtis; Gary Falk; M Brian Fennerty; Grant Fullarton; Kausilia Krishnadath; Stephen J Meltzer; David Armstrong; Robert Ganz; Gianpaolo Cengia; James J Going; John Goldblum; Charles Gordon; Heike Grabsch; Chris Haigh; Michio Hongo; David Johnston; Ricky Forbes-Young; Elaine Kay; Philip Kaye; Toni Lerut; Laurence B Lovat; Lars Lundell; Philip Mairs; Tadakuza Shimoda; Stuart Spechler; Stephen Sontag; Peter Malfertheiner; Iain Murray; Manoj Nanji; David Poller; Krish Ragunath; Jaroslaw Regula; Renzo Cestari; Neil Shepherd; Rajvinder Singh; Hubert J Stein; Nicholas J Talley; Jean-Paul Galmiche; Tony C K Tham; Peter Watson; Lisa Yerian; Massimo Rugge; Thomas W Rice; John Hart; Stuart Gittens; David Hewin; Juergen Hochberger; Peter Kahrilas; Sean Preston; Richard Sampliner; Prateek Sharma; Robert Stuart; Kenneth Wang; Irving Waxman; Chris Abley; Duncan Loft; Ian Penman; Nicholas J Shaheen; Amitabh Chak; Gareth Davies; Lorna Dunn; Yngve Falck-Ytter; John Decaestecker; Pradeep Bhandari; Christian Ell; S Michael Griffin; Stephen Attwood; Hugh Barr; John Allen; Mark K Ferguson; Paul Moayyedi; Janusz A Z Jankowski
Journal:  Gastroenterology       Date:  2012-04-24       Impact factor: 22.682

Review 4.  Pathogen recognition by the innate immune system.

Authors:  Himanshu Kumar; Taro Kawai; Shizuo Akira
Journal:  Int Rev Immunol       Date:  2011-02       Impact factor: 5.311

5.  Toll-like receptor 5 activation promotes migration and invasion of salivary gland adenocarcinoma.

Authors:  Jong-Hwan Park; Hyo-Eun Yoon; Dong-Jae Kim; Soo-A Kim; Sang-Gun Ahn; Jung-Hoon Yoon
Journal:  J Oral Pathol Med       Date:  2010-08-31       Impact factor: 4.253

6.  Flagellin administration protects gut mucosal tissue from irradiation-induced apoptosis via MKP-7 activity.

Authors:  Rheinallt M Jones; Valerie M Sloane; Huixia Wu; Liping Luo; Amrita Kumar; Matam Vijay Kumar; Andrew T Gewirtz; Andrew S Neish
Journal:  Gut       Date:  2011-01-03       Impact factor: 23.059

7.  Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia.

Authors:  Pedro Pimentel-Nunes; Luís Afonso; Paula Lopes; Roberto Roncon-Albuquerque; Nádia Gonçalves; Rui Henrique; Luís Moreira-Dias; Adelino F Leite-Moreira; Mário Dinis-Ribeiro
Journal:  Pathol Oncol Res       Date:  2011-04-01       Impact factor: 3.201

8.  Nucleic acid-sensing toll-like receptors 3, 7 and 8 in esophageal epithelium, barrett's esophagus, dysplasia and adenocarcinoma.

Authors:  Olli Helminen; Heikki Huhta; Petri P Lehenkari; Juha Saarnio; Tuomo J Karttunen; Joonas H Kauppila
Journal:  Oncoimmunology       Date:  2016-01-25       Impact factor: 8.110

9.  Paired exome analysis of Barrett's esophagus and adenocarcinoma.

Authors:  Matthew D Stachler; Amaro Taylor-Weiner; Shouyong Peng; Aaron McKenna; Agoston T Agoston; Robert D Odze; Jon M Davison; Katie S Nason; Massimo Loda; Ignaty Leshchiner; Chip Stewart; Petar Stojanov; Sara Seepo; Michael S Lawrence; Daysha Ferrer-Torres; Jules Lin; Andrew C Chang; Stacey B Gabriel; Eric S Lander; David G Beer; Gad Getz; Scott L Carter; Adam J Bass
Journal:  Nat Genet       Date:  2015-07-20       Impact factor: 38.330

10.  Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma.

Authors:  Heikki Huhta; Olli Helminen; Petri P Lehenkari; Juha Saarnio; Tuomo J Karttunen; Joonas H Kauppila
Journal:  Oncotarget       Date:  2016-04-26
View more
  5 in total

1.  High CHD9 expression is associated with poor prognosis in clear cell renal cell carcinoma.

Authors:  Bo Guan; Xian-Gui Ran; Yong-Qiang Du; Feng Ren; Ye Tian; Ying Wang; Ming-Min Chen
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

Review 2.  Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach.

Authors:  Jin-On Jung; Henrik Nienhüser; Nikolai Schleussner; Thomas Schmidt
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

3.  Predictive value of p53, Ki67 and TLR5 in neoplastic progression of Barrett's esophagus: a matched case-control study.

Authors:  Olli Helminen; Jukka Melkko; Juha Saarnio; Eero Sihvo; Teijo Kuopio; Pasi Ohtonen; Joonas H Kauppila; Tuomo J Karttunen; Heikki Huhta
Journal:  Virchows Arch       Date:  2022-05-26       Impact factor: 4.535

Review 4.  Microbial Colonization and Inflammation as Potential Contributors to the Lack of Therapeutic Success in Oral Squamous Cell Carcinoma.

Authors:  Zoya Kurago; Jenni Loveless
Journal:  Front Oral Health       Date:  2021-10-04

5.  Mucosa-Associated Microbiota in Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma Differ Similarly Compared With Healthy Controls.

Authors:  Shajan Peter; Amanda Pendergraft; William VanDerPol; C Mel Wilcox; Kondal R Kyanam Kabir Baig; Casey Morrow; Jacques Izard; Peter J Mannon
Journal:  Clin Transl Gastroenterol       Date:  2020-08       Impact factor: 4.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.